ArticleBMC urology2022

Multi-country clinical practice patterns, including use of biomarkers, among physicians' treatment of BCG-unresponsive non-muscle invasive bladder cancer (NMIBC).

Edward I Broughton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.